CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.949
4.91%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.152
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.998
Open* 0.995
1-Year Change* 11.92%
Day's Range* 0.899 - 1.019
52 wk Range 0.20-1.17
Average Volume (10 days) 677.47K
Average Volume (3 months) 3.19M
Market Cap 25.02M
P/E Ratio -100.00K
Shares Outstanding 68.60M
Revenue 13.18M
EPS -0.58
Dividend (Yield %) N/A
Beta 0.54
Next Earnings Date Dec 4, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 22, 2023 0.949 -0.012 -1.25% 0.961 1.019 0.899
Sep 21, 2023 0.998 0.042 4.39% 0.956 1.019 0.909
Sep 20, 2023 0.959 -0.026 -2.64% 0.985 1.019 0.921
Sep 19, 2023 1.029 0.020 1.98% 1.009 1.109 0.979
Sep 18, 2023 1.019 -0.110 -9.74% 1.129 1.149 0.998
Sep 15, 2023 1.059 0.074 7.51% 0.985 1.169 0.949
Sep 14, 2023 0.939 0.009 0.97% 0.930 1.009 0.889
Sep 13, 2023 0.998 0.092 10.15% 0.906 1.049 0.895
Sep 12, 2023 0.998 0.039 4.07% 0.959 1.009 0.889
Sep 11, 2023 0.998 0.123 14.06% 0.875 1.009 0.869
Sep 8, 2023 1.008 0.011 1.10% 0.997 1.048 0.953
Sep 7, 2023 0.958 -0.039 -3.91% 0.997 1.008 0.878
Sep 6, 2023 0.978 -0.030 -2.98% 1.008 1.098 0.958
Sep 5, 2023 1.038 0.214 25.97% 0.824 1.078 0.750
Sep 1, 2023 0.758 -0.117 -13.37% 0.875 0.884 0.638
Aug 31, 2023 0.888 0.094 11.84% 0.794 0.968 0.748
Aug 30, 2023 0.788 0.043 5.77% 0.745 0.864 0.678
Aug 29, 2023 0.678 0.050 7.96% 0.628 0.728 0.590
Aug 28, 2023 0.498 0.045 9.93% 0.453 0.578 0.389
Aug 25, 2023 0.446 0.123 38.08% 0.323 0.640 0.287

Akso Health Group Events

Time (UTC) Country Event
Monday, December 4, 2023

Time (UTC)

00:30

Country

US

Event

Half Year 2024 Akso Health Group Earnings Release
Half Year 2024 Akso Health Group Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 13.1816 6 0 6.91447 3.69522
Revenue 13.1816 6 0 6.91447 3.69522
Total Operating Expense 27.4484 9.26046 4.24125 55.0202 10.8844
Selling/General/Admin. Expenses, Total 15.5358 3.06146 2.08663 22.2991 10.8844
Research & Development 1.03256 0
Operating Income -14.2669 -3.26046 -4.24125 -48.1057 -7.18919
Other, Net 1.20036 -0.74782 -0.05208 1.23216 0.38115
Net Income Before Taxes -13.0665 -4.00828 -4.29333 -46.8735 -6.80804
Net Income After Taxes -13.084 -4.1011 -4.29333 -47.3635 -7.61575
Net Income Before Extra. Items -13.1965 -4.10243 -4.29333 -47.3635 -7.61575
Net Income -1.35992 -16.8511 -34.827 -71.1984 5.53258
Income Available to Common Excl. Extra. Items -13.1965 -4.10243 -4.29333 -47.3635 -7.61575
Income Available to Common Incl. Extra. Items -1.35992 -16.8511 -34.827 -71.1984 5.53258
Dilution Adjustment
Diluted Net Income -1.35992 -16.8511 -34.827 -71.1984 5.53258
Diluted Weighted Average Shares 68.5981 59.6121 48.838 48.7572 48.6932
Diluted EPS Excluding Extraordinary Items -0.19237 -0.06882 -0.08791 -0.97142 -0.1564
Diluted Normalized EPS -0.19237 -0.06882 -0.08791 -0.58227 -0.1564
Minority Interest -0.1125 -0.00133
Interest Expense (Income) - Net Operating 0 0.80414 2.15462 2.49871 0
Unusual Expense (Income) 29.1898 0
Total Extraordinary Items 11.8366 -12.7486 -30.5337 -23.8349 13.1483
Cost of Revenue, Total 11.9126 5.39487 0
Gross Profit 1.26899 0.60513 0
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total revenue 1.30914 11.8724 5.75408 0.24592 0
Revenue 1.30914 11.8724 5.75408 0.24592 0
Total Operating Expense 14.5258 12.9226 0.54471 8.71575 4.24125
Selling/General/Admin. Expenses, Total 13.3444 2.10033 0.22 2.84146 2.08663
Research & Development 0.09108 -0.24023 0.24023
Interest Expense (Income) - Net Operating 0 0 0.20414 0.6 2.15462
Other Operating Expenses, Total -5.03406 5.03406
Operating Income -13.2167 -1.05019 5.20937 -8.46983 -4.24125
Other, Net -0.68801 1.88837 -0.31943 -0.42838 -0.05208
Net Income Before Taxes -13.9047 0.83818 4.88993 -8.89821 -4.29333
Net Income After Taxes -13.9105 0.82644 4.81502 -8.91611 -4.29333
Net Income Before Extra. Items -14.0069 0.81034 4.81369 -8.91611 -4.29333
Net Income -2.17026 0.81034 -7.93495 -8.91611 -34.827
Income Available to Common Excl. Extra. Items -14.0069 0.81034 4.81369 -8.91611 -4.29333
Income Available to Common Incl. Extra. Items -2.17026 0.81034 -7.93495 -8.91611 -34.827
Diluted Net Income -2.17026 0.81034 -7.93495 -8.91611 -34.827
Diluted Weighted Average Shares 68.5981 68.5981 68.549 50.6754 48.838
Diluted EPS Excluding Extraordinary Items -0.20419 0.01181 0.07022 -0.17595 -0.08791
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.20419 0.01181 0.07022 -0.17595 -0.08791
Unusual Expense (Income)
Total Extraordinary Items 11.8366 -12.7486 0 -30.5337
Cost of Revenue, Total 1.18137 10.7312 5.39487
Gross Profit 0.12777 1.14122 0.35921
Minority Interest -0.0964 -0.0161 -0.00133
Total Adjustments to Net Income 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 50.6244 30.1225 52.0182 97.6806 163.123
Cash and Short Term Investments 21.9253 15.1287 6.6681 57.3721 132.622
Cash & Equivalents 21.9253 15.1287 6.6681 57.3721 132.622
Total Receivables, Net 20.0152 14.401 36.2627 36.9735 29.2517
Prepaid Expenses 0.88796 0.59278 0.40082 3.33497 1.24856
Total Assets 50.6798 31.6855 80.4762 173.256 163.89
Property/Plant/Equipment, Total - Net 0.05543 0.06689 0.76357 1.25372 0.76709
Note Receivable - Long Term 0 1.49612 22.3081 39.8105
Other Long Term Assets, Total 3.78633 3.72118 0
Total Current Liabilities 38.3942 14.414 12.3618 26.5627 23.8468
Accrued Expenses 1.06905 1.14251 1.89035 2.7911 3.78696
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 37.3251 3.27146 10.4714 23.7716 20.0598
Total Liabilities 38.3962 14.414 32.3753 46.7527 23.8468
Total Long Term Debt 0 0 20 20 0
Total Equity 12.2836 17.2715 48.1009 126.503 140.043
Common Stock 0.00698 0.005 0.005 0.00496 0.0048
Additional Paid-In Capital 71.0219 60.6151 60.5596 59.8069 58.418
Retained Earnings (Accumulated Deficit) -53.1077 -36.2566 -1.42962 69.7688 77.2411
Other Equity, Total -1.64922 -3.10354 -7.0457 -1.75696 4.37923
Total Liabilities & Shareholders’ Equity 50.6798 31.6855 80.4762 173.256 163.89
Total Common Shares Outstanding 68.5981 48.8506 48.8183 49.2041 15.986
Accounts Receivable - Trade, Net 0.01525 0.02836 0.00188 0.41864
Property/Plant/Equipment, Total - Gross 0.14131 0.13197 0.80927 1.99927
Accumulated Depreciation, Total -0.08588 -0.06508 -0.0457 -0.74555
Long Term Investments 0 1.6 30.7898
Long Term Debt 0 20 20
Other Liabilities, Total 0 0.0135 0.18996
Treasury Stock - Common -3.98837 -3.98837 -3.98837 -1.32047
Other Current Assets, Total 0 8.68651
Current Port. of LT Debt/Capital Leases 0 10 0
Total Inventory 7.79582
Minority Interest 0.00198
Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
Total Current Assets 20.871 50.6244 22.3104 30.1225 47.8994
Cash and Short Term Investments 9.99056 21.9253 15.4568 15.1287 21.9013
Cash & Equivalents 9.99056 21.9253 15.4568 15.1287 21.9013
Total Receivables, Net 7.92858 20.0152 6.56152 14.3892 18.2805
Accounts Receivable - Trade, Net 7.92858 0.01525 0.01776 0.02836 0.28878
Prepaid Expenses 2.05229 0.88796 0.29201 0.60452 0.71759
Total Assets 20.9073 50.6798 32.5244 31.6855 60.181
Property/Plant/Equipment, Total - Net 0.03631 0.05543 0.06881 0.06689 0.07214
Long Term Investments 0 1.6
Note Receivable - Long Term 0 0 1.49612 10.6095
Other Long Term Assets, Total 10.1453 0
Total Current Liabilities 10.9772 38.3942 12.9722 14.414 13.1289
Accrued Expenses 1.18238 1.06905 0.945 1.14251 1.35086
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 9.79486 37.3251 2.02725 3.27146 11.7781
Total Liabilities 10.9944 38.3962 12.9722 14.414 33.1289
Total Long Term Debt 0 0 0 0 20
Long Term Debt 0 20
Other Liabilities, Total 0 0
Total Equity 9.91285 12.2836 19.5522 17.2715 27.052
Common Stock 0.00698 0.00698 0.00698 0.005 0.005
Additional Paid-In Capital 71.0219 71.0219 71.0219 60.6151 60.6151
Retained Earnings (Accumulated Deficit) -52.2973 -53.1077 -45.1727 -36.2566 -25.0173
Treasury Stock - Common -3.98837 -3.98837 -3.98837 -3.98837 -3.98837
Other Equity, Total -4.83032 -1.64922 -2.31557 -3.10354 -4.56238
Total Liabilities & Shareholders’ Equity 20.9073 50.6798 32.5244 31.6855 60.181
Total Common Shares Outstanding 68.5981 68.5981 68.5981 48.8506 48.8572
Other Current Assets, Total 0 7.00003
Current Port. of LT Debt/Capital Leases 0 10 10
Total Inventory 0.89956 7.79582
Minority Interest 0.01721 0.00198
Property/Plant/Equipment, Total - Gross 0.12593
Accumulated Depreciation, Total -0.08962
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -16.8497 -31.5522 -47.3635 5.53258 65.5106
Cash From Operating Activities -8.62837 10.0585 -58.2787 -1.73108 87.723
Cash From Operating Activities 0.01839 0.01516 0.12052 0.4068 0.17438
Deferred Taxes 0 0 3.3083 -3.72408 0.41562
Changes in Working Capital -2.56415 23.2255 -32.9 -11.6206 19.7935
Cash From Investing Activities -19.9639 -0.00066 12.7754 -68.1066 -27.6238
Capital Expenditures -0.00486 0 -0.20036 -0.94481 -0.45603
Cash From Financing Activities 34.7811 -9.03722 -1.55219 -0.02938 47.5163
Financing Cash Flow Items 10.0172 0.03694 7.36367 -0.318 4.24256
Issuance (Retirement) of Stock, Net 0 0.00001 -2.26261 -0.16385 43.2737
Foreign Exchange Effects 0.60772 3.18293 0.60864 -5.38333 5.77472
Net Change in Cash 6.7966 4.20351 -46.4469 -75.2503 113.39
Non-Cash Items 10.7671 18.3701 18.556 7.67422 1.82887
Cash Taxes Paid 0.03862 0.00976 3.20938 12.2482 1.01696
Other Investing Cash Flow Items, Total -19.959 -0.00066 12.9757 -67.1617 -27.1678
Total Cash Dividends Paid 0 0 -19.5475
Issuance (Retirement) of Debt, Net 24.7639 -9.07416 -6.65324 20
Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
Net income/Starting Line 0.82644
Cash From Operating Activities -1.33412
Cash From Operating Activities 0.01384
Non-Cash Items 0
Changes in Working Capital -2.17439
Cash From Investing Activities 20
Other Investing Cash Flow Items, Total 20
Cash From Financing Activities -27.5138
Financing Cash Flow Items -27.5138
Foreign Exchange Effects -3.0868
Net Change in Cash -11.9348
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Renaissance Technologies LLC Hedge Fund 0.8998 214398 -19300 2023-06-30 HIGH
Two Sigma Investments, LP Hedge Fund 0.4789 114093 -6920 2023-06-30 HIGH
Rhumbline Advisers Ltd. Partnership Investment Advisor 0.0837 19940 19940 2023-06-30 LOW
HRT Financial LP Investment Advisor 0.0423 10073 10073 2023-06-30 HIGH
Morgan Stanley & Co. LLC Research Firm 0.0141 3370 0 2023-06-30 MED

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Akso Health Group Company profile

About Akso Health Group - ADR

Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others.

Financial summary

BRIEF: For the six months ended 30 September 2021, AksoHealth Group - ADR revenues decreased 82% to $246K. Netloss before extraordinary items decreased 49% to $8.9M.Revenues reflect Interest income decrease of 82% to $187K,Commission services decrease of 81% to $60K. Lower net lossreflects Provision for uncollectable loans receiv decreaseof 61% to $5M (expense), General and administrativedecrease of 25% to $2.3M (expense).

Industry: E-commerce & Auction Services

Room 515, Floor 5, Jia No. 92-4 To 24
Jianguo Road Chaoyang Dist
BEIJING
BEIJING 100020
CN

Income Statement

  • Annual
  • Quarterly

News

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

Cable coils near lows ahead of Fed and BoE rate decisions

It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

14:16, 19 September 2023

FTSE 100 Technical Outlook - 18 September 2023

In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

06:55, 19 September 2023
View of the City of London’s illuminated financial district skyline at dusk

Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

13:46, 15 September 2023

People also watch

ETH/USD

1,579.80 Price
-0.800% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Oil - Crude

90.00 Price
-0.120% 1D Chg, %
Long position overnight fee 0.0414%
Short position overnight fee -0.0633%
Overnight fee time 21:00 (UTC)
Spread 0.030

XRP/USD

0.50 Price
-2.310% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

US100

14,691.10 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading